Well, I don’t think Prof MP was wondering where it would go, it will more than likely go where the data held by Elanco, Eli Lilly and the FDA is available, where they are most desperate economically, and have the Deepest pockets. If this is a lot better than Remdesivir as the Professor no doubt thinks/hopes it could be based on that one chart (given it is Monepantel on the chart). The big question is how much? I don’t imagine any company is going to take the time to organise some sort of royalty scheme instead of just buying PAA out.
I know....let’s not count our eggs...
Well, I don’t think Prof MP was wondering where it would go, it...
-
- There are more pages in this discussion • 25 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
17.5¢ |
Change
-0.005(2.78%) |
Mkt cap ! $85.12M | |||
| Open | High | Low | Value | Volume |
| 18.0¢ | 18.5¢ | 17.5¢ | $59.53K | 337.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 518045 | 17.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 18.0¢ | 34777 | 2 |
View Market Depth
| Last trade - 16.10pm 05/09/2024 (20 minute delay) ? |
| PAA (ASX) Chart |